Search results
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 2 days agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 2 days agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 2 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
What's Going With Pfizer Stock On Wednesday? - Pfizer (NYSE:PFE)
Benzinga· 2 days agoOn Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year,...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 2 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Pfizer reports dip in first quarter profits, yet beats estimates
dpa international via Yahoo Finance· 2 days agoThe US pharmaceutical giant Pfizer on Wednesday said its earnings for the first quarter had declined...
Pfizer Inc. (PFE): A New Perspective – Stocks Register
Stocks Register· 1 day agoPfizer Inc. (NYSE:PFE) concluded the trading at $27.18 on Wednesday, May 01, with a rise of 6.09% from its closing price on previous day. Taking a look at stock we notice ...
With 54% ownership of the shares, Haleon plc (LON:HLN) is heavily dominated by institutional owners
Simply Wall St. via Yahoo Finance· 47 minutes agoHedge funds don't have many shares in Haleon. Our data shows that Pfizer Inc. is the largest...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 4 days agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 2 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...